Data / Form D filings / RedPath Integrated Pathology, Inc.
RedPath Integrated Pathology, Inc.: Form D filings
RedPath Integrated Pathology, Inc., a biotechnology company in Pittsburgh, PA, filed 3 Form D notices with the SEC between 2011 and 2013. The latest, on April 9, 2013, reports $612,500 sold of a $800,000 offering to 8 investors.
Find out what RedPath Integrated Pathology, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2515 Liberty Avenue, Pittsburgh, PA, 15222
- Phone
- (412) 562-8800
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1308149
The full lists. Form D filings in Pennsylvania: 987 rows, $49.35, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 9, 2013 | New notice | $800,000 | $612,500 | $187,500 | 8 | Mar 25, 2013 | sec.gov |
| Aug 3, 2012 | New notice | $1,366,987 | $588,218 | $778,769 | 10 | Jul 19, 2012 | sec.gov |
| May 16, 2011 | New notice | $2,000,000 | $1,600,000 | $400,000 | 12 | Mar 31, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Brian Murphy | Director | |
| Peter Kleinhenz | Director | |
| Dennis Smith | Executive Officer, Director | |
| Jack Davis | Director |
Other biotechnology companies in Pennsylvania that filed recently
- Traws Pharma, Inc. offering · Nov 5, 2026
- BioLattice Ophthalmics, Inc, $1.8 million · Oct 28, 2026
- Myris Therapeutics, Inc. $500,000 · Oct 14, 2026
- Praeventix, Inc. $5.6 million · Sep 10, 2026
- Plowshare Therapies LLC $6.7 million · Aug 31, 2026
- Noveome Biotherapeutics, Inc. $6.8 million · Aug 27, 2026
- AlloTRx Bio Inc. $500,000 · Aug 24, 2026
- Aposture Surgical Corp $87,000 · Aug 13, 2026
- Merlin Biotech, Inc. $50,000 · Aug 11, 2026
Every Form D from the week of Apr 8, 2013 · All recent filings in Pennsylvania · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what RedPath Integrated Pathology, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.